pafencil has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bliumental', RIa; Iavorkovskiĭ, LI; Rotsena, AIa; Udris, OIu; Zile, MA | 1 |
| Arkhipova, NE; Burova, GF; Chernova, MK; Tentsova, IA; Tolmacheva, EL | 1 |
2 other study(ies) available for pafencil and Lymphoma
| Article | Year |
|---|---|
[Therapeutic results in malignant lymphomas treated by the COPP and POPP drug administration schedules].
Topics: 4-Aminobenzoic Acid; Adult; Aged; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lymphoma; Male; Middle Aged; Nitrogen Mustard Compounds; para-Aminobenzoates; Prednisolone; Procarbazine; Vincristine | 1981 |
[Direct results of using a new multimodal chemotherapy plan in malignant non-Hodgkin lymphomas].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Humans; Lymphoma; Nitrogen Mustard Compounds; Prednisolone; Time Factors | 1981 |